“The fact that we do not have structured protocols in place for diagnosing or treating pain as we do with other diseases is part and parcel of why people get addicted,” says Mr. Paradise. “Topricin represents a 21st century approach to pain management—reducing and/or preventing addiction, promoting healthy lifestyle—and is leading the charge for a sustainable healthcare model by addressing the causes of over medication and addiction and how pain should be looked at in the same structured protocols as diabetes, obesity, cancer, etc.”
Topical BioMedics is continuing to deepen its research into Topricin throughout 2013 in cooperation with Dr. Robert S. Gotlin, Director of Orthopedic and Sports Medicine at Beth Israel Medical Center, Continuum Center for Health and Healing, New York. The study will explore Topricin’s role in treatment protocol for various muscular/skeletal and neuropathic pain issues, with the hopes of addressing opioid addiction issues while demonstrating a model for appropriate care, profitability and sustainability can exist.
ABOUT THE 2013 INTEGRATIVE HEALTHCARE SYMPOSIUM
The IHS brings together multi-disciplinary healthcare professionals dedicated to improving patient care and defining the future of integrative healthcare. Sponsored by Beth Israel Medical Center’s Continuum Center for Health and Healing, the conference chair is Woodson C. Merrell, MD, Department of Integrative Medicine, executive director, CCHH, Beth Israel Medical Center and assistant clinical professor of medicine, Columbia University College of Physicians and Surgeons.
ABOUT TOPICAL BIOMEDICS, INC.
Topical BioMedics is the research and development leader in topical patented natural biomedicines for pain relief. The company’s flagship product, Topricin® Pain Relief and Healing Cream, was introduced in 1994 and is now a leading natural therapeutic brand. A combinat
Copyright©2012 Vocus, Inc.
All rights reserved